$3.75
0.16[4.46%]
At close: Apr 19
$3.75
0[0.00%]
After Hours: 5:29PM EDT
Humacyte
(NASDAQ:HUMA)Latest News for Humacyte Stock (NASDAQ:HUMA)
Humacyte Stock (NASDAQ: HUMA)
Categories: All
Friday, April 19, 2024
- Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - 4 hours ago
- Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On FridayAvi Kapoor - 7 hours ago
Thursday, April 18, 2024
Wednesday, April 17, 2024
Monday, April 01, 2024
Tuesday, March 26, 2024
Monday, March 25, 2024
Friday, March 22, 2024
- Humacyte Q4 EPS $(0.24), Inline; Humacyte Says Its Cash And Cash Equivalents Of $80.4M, Net Proceeds Of $43.1M From The March Offering And Additional Draw Of $20M Under The Oberland Funding Arrangement, Will Provide Cash Runway For At Least 12 MonthsBenzinga Newsdesk - Mar 22, 2024, 7:04AM
- Earnings Scheduled For March 22, 2024Benzinga Insights - Mar 22, 2024, 5:40AM
- Investor Optimism Improves Slightly; Dow Jumps Over 250 PointsAvi Kapoor - Mar 22, 2024, 2:53AM
Thursday, March 21, 2024
Tuesday, March 19, 2024
Friday, March 08, 2024
Friday, March 01, 2024
- Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Mar 1, 2024, 1:19PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Mar 1, 2024, 12:34PM
- Why Humacyte (HUMA) Shares Are FallingHenry Khederian - Mar 1, 2024, 10:44AM
- Humacyte shares are trading lower after the company announced pricing of a $40.2 million public offering of common stock.Benzinga Newsdesk - Mar 1, 2024, 8:46AM
- Why NetApp Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Mar 1, 2024, 8:31AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Mar 1, 2024, 8:09AM
- Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market SessionAvi Kapoor - Mar 1, 2024, 5:47AM
- Reported Earlier, Humacyte Prices $40.2M Public Offering Of 13.4M Common Stock At $3/ShareBenzinga Newsdesk - Mar 1, 2024, 3:08AM
Thursday, February 29, 2024
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Feb 29, 2024, 4:31PM
- Humacyte shares are trading lower after the company announced a proposed public offering of common stock.Benzinga Newsdesk - Feb 29, 2024, 4:26PM
- Humacyte, Inc. Announces Proposed Public Offering Of Common StockBenzinga Newsdesk - Feb 29, 2024, 4:04PM
Friday, February 09, 2024
- Humacyte shares are trading higher after the company announced that the FDA has accepted and granted Priority Review to its Biologics License Application that seeks approval of the Human Acellular Vessel for the treatment of vascular trauma.Benzinga Newsdesk - Feb 9, 2024, 3:22PM
- Why Is Clinical-Stage Biotechnology Platform Company Humacyte Stock Gaining Friday?Nabaparna Bhattacharya - Feb 9, 2024, 1:06PM
- Humacyte Announces FDA Has Accepted And Granted For Priority Review The Company's Biologics License Application Seeking Approval Of Human Acellular VesselBenzinga Newsdesk - Feb 9, 2024, 8:01AM
Wednesday, January 31, 2024
Tuesday, January 23, 2024
Tuesday, January 09, 2024
Tuesday, January 02, 2024
Wednesday, December 27, 2023
Tuesday, December 19, 2023
Tuesday, December 12, 2023
Monday, December 11, 2023
Friday, November 17, 2023
Friday, November 10, 2023
Thursday, November 09, 2023
- Humacyte Q3 EPS $(0.25), InlineBenzinga Newsdesk - Nov 9, 2023, 4:56PM
- Humacyte Cash And Cash Equivalents As Of Sept. 30 $100MBenzinga Newsdesk - Nov 9, 2023, 4:46PM
- Humacyte: Q3 Earnings InsightsBenzinga Insights - Nov 9, 2023, 4:05PM
- Earnings Scheduled For November 9, 2023Benzinga Insights - Nov 9, 2023, 6:52AM
Wednesday, November 08, 2023
Monday, October 16, 2023
Thursday, September 21, 2023
Tuesday, September 12, 2023
- Regenerative Medicine Firm Humacyte's Bioengineered Tissue Shows Promise In Trauma InjuriesVandana Singh - Sep 12, 2023, 2:31PM
- Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Sep 12, 2023, 1:44PM
- Why Matrix Service Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving PremarketLisa Levin - Sep 12, 2023, 8:00AM
- Humacyte Announced Topline Results From V005 Phase 2/3 Trial Of Human Acellular Vessel (HAV) In Vascular Trauma Repair, Showing That HAV Had Higher Rates Of Patency, Lower Rates Of Amputation And Infection, Compared To Historic Synthetic Graft BenchmarksBenzinga Newsdesk - Sep 12, 2023, 7:05AM